New perspectives on heart failure due to myocardial ischaemia

European Heart Journal

Volumn 20, Issue 4, 1999, Pages 256-262

  Fox, K F ^a   Cowie, M R ^a   Wood, D A ^a   Coats, A J S ^a   Poole Wilson, P A ^a   Sutton, G C ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b HILLINGDON HOSPITAL   (United Kingdom)

Author keywords

Coronary artery disease; Epidemiology; Heart failure; Prevention; Revascularization; Viability

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL;

HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REVASCULARIZATION; HUMAN; MYOCARDIAL HIBERNATION; PRIORITY JOURNAL; REVIEW;

CAUSE OF DEATH; CLINICAL TRIALS; FEMALE; GREAT BRITAIN; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MALE; MYOCARDIAL ISCHEMIA; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE;

EID: 0032997516     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1221     Document Type: Review

References (65)

1. Parameshwar J, Shackell MM, Richardson A, Poole-Wilson PA, Sutton GC. Prevalence of heart failure in three general practices in north west London. Br J Gen Practice. 42:1992;287-289.
2. McMurray J, Hart W, Rhodes G. An evaluation of the economic cost of heart failure to the National Health Service in the United Kingdom. Br J Med Econ. 6:1993;99-110.
3. Ghali JK, Kay R, Shelton B. Contemporary aetiologies of left ventricular dysfunction and/or heart failure and their influence on prognosis. Circulation. 86 (Suppl):1992;2380.
4. Cowie MR, Mosterd A, Wood DA. The epidemiology of heart failure. Eur Heart J. 18:1997;208-225.
5. Opie LH. The multifarious spectrum of ischaemic left ventricular dysfunction: Relevance of new ischaemic syndromes. J Mol Cell Cardiol. 28:1996;2403-2414.
6. Cowie, MR, Wood, DA, Coats, A, Incidence and aetiology of heart failure: a population-based study, Eur Heart J.
7. McKee PA, Castell WP, Mcnamara PM, Kannel WP. The natural history of congestive heart failure: The Framingham study. N Engl J Med. 285:1971;1441-1445.
8. Remes J, Reunanen A, Aromaa A, Pyorala K. Incidence of heart failure in eastern Finland: a population-based surveillance study. Eur Heart J. 13:1992;588-593.
9. Brookes CIO, Hart P, Keogh BE, Cleland JGF. Angiography and the aetiology of heart failure. Postgrad Med J. 71:1995;480-504.
10. Bortman G, Sellanes M, Odell DS, Ring WS, Olivari M. Discrepency between Pre- and Post-diagnosis of end-stage dilated cardiomyopathy. Am J Cardiol. 74:1994;921-924.
11. Fox KF, Cowie MR, Wood DA. Prevalence of coronary artery disease in new cases of heart failure: a population study. (Abstr) Eur Heart J. 19 (Abstr Suppl):1998;S223.
12. Braunwald E. Myocardial Infarction. Diseases of the Heart, 6th edn. 1996;WB Saunders, Philadelphia. p. 1184-1288.
13. The ISIS-2 collaborative group. Randomised trial of intra-venous streptokinase, oral aspirin, both or neither among 17187 cases of suspeted myocardial infarction: ISIS-2. Lancet. ii:1988;349-360.
14. Stevenson R, Ranjadayalan K, Wilkinson P, Roberts R, Timis AD. Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis. Br Med J. 307:1993;349-353.
15. Opie LH. Myocardial ischaemia - metabolic pathways and implications of increased glycolysis. Cardiovasc Drugs Ther. 4:1990;777-790.
16. Clarke K, O'Connor AJ, Willis RJ. Temporal relation between energy metabolism and myocardial function during ischaemia and reperfusion. Am J Physiol. 253:1987;H412-H421.
17. Deanfield JE, Maseri A, Selwyn AP. Myocardial ischaemia during daily life inpatients with stable angina: its relation to symptoms and heart rate changes. Lancet. 2:1983;753-758.
18. Gunning MG, Mulcahy D, Patel D. Recurrent transient ischaemic episodes during daily life do not cause deterioration in left ventricular function. A long-term follow-up study (Abstr). Eur Heart J. 16 (Abstr Suppl):1995;S421.
19. Heyndrickx GR, Millard RW, McRitchie RJ, Maroko PR, Vatner SF. Regional myocardial function and electrophysiological alterations after brief coronary occlusion in conscious dogs. J Clin Invest. 56:1975;978-985.
20. Serruys PW, Wijns W, van den Brandt M. Left ventricular performance, regional blood flow, wall motion, and lactate metabolism during transluminal angioplasty. Circulation. 70:1994;25-36.
21. Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echo-cardiography. Circulation. 658:1982;1497-1503.
22. Du Toit J, Opie LH. Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res. 70:1992;960-967.
23. Ehring TE, Heusch G. Stunned myocardium and the attenuation of stunning by calcium antagonists. Am J Cardiol. 75:1995;61E-67E.
24. Shen Y-T, Vatner SF. Mechanism of impaired myocardial function during progressive coronary stenosis in conscious pigs. Hibernation versus stunning. Circ Res. 76:1995;479-488.
25. Rahimtoola SH. A perspective on three large multicenter randomised clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 72 (Supp V):1985;123-125.
26. Rahimtoola SH. The hibernating myocardium. Am Heart J. 117:1989;211-221.
27. Ross Jr J. Myocardial perfusion-contraction matching: implications for coronary heart disease and hibernation. Circulation. 83:1991;1076-1082.
28. Hearse DJ. Myocardial hibernation. A form of endogenous protection? Eur Heart J. 18 (Suppl A):1997;A2-A7.
29. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation. 74:1986;1124-1136.
30. Speechly-Dick ME, Glover GJ, Yellon DM. Does ischaemic preconditioning in the human heart involve protein kinase C and the ATP-dependent K+ channel? Studies in an atrial in vivo model. Circ Res. 77:1995;1030-1035.
31. Kloner RA, Yellon DM. Does ischaemic preconditioning occur in patients. J Am Coll Cardiol. 24:1994;1133-1142.
32. Tillisch JG, Brunken R, Marshall R. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med. 315:1986;884-888.
33. Dilsizian V, Arrighi JA, Diodatti JG. Myocardial viability inpatients with chronic coronary artery disease Comparison of 99mTc-Sestamibi with thallium reinjection and [18F]Fluorodeoxyglucose. Circulation. 89:1994;578-587.
34. Cigarroa CG, de Fillippi CR, Brickner ME. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularisation. Circulation. 88:1993;430-436.
35. Baer FM, Voth E, Schneider CA. Comparison of low-dose dobutamine-gradient echo magnetic resonance imaging and positron emission tomography with [18F] fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation. 91:1995;1006-1015.
36. Beller GA. Assessment of myocardial viability. Curr Opinion Cardiol. 12:1997;459-467.
37. Perrone-Filarde P, Pace L, Prastaro M. Dobutamine echocardiography predicts improvement of hypoperfused dysfunctional myocardium after revascularisation in patients with coronary artery disease. Circulation. 91:1995;2256-2265.
38. LaCanna G, Alfieri O, Giubbini R. Echocardiography during infusion of dobutamine for identification of reversible dysfunction in patients with chronic coronary artery disease. J Am Coll Cardiol. 23:1994;617-626.
39. Di Carli MF, Asgarzadie BA, Schelbert HR. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularisation in patients with ischaemic cardiomyopathy. Circulation. 92:1995;3436-3444.
40. Bonow RO. The hibernating myocardium: Implications for the management of congestive heart failure. Am J Cardiol. 75:1995;17A-25A.
41. Cowie MR, Suresh V, Wood DA. The prognosis of heart failure: a population-based series. (Abstr) Eur Heart J. 18:1997;S596.
42. Clark ML, Price AB, Williams CB. Tumours of the gastro-intestinal tract. Weatherall DJ, Ledingham JGG, Warrell DA. Oxford Textbook of Medicine, 3rd edn. 1996;1980-1994 Oxford University Press, Oxford.
43. Ho KK, Pisky JL, Kannel WB, Levy D. The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol. 22:1993;6A-13A.
44. Franciosa JA, Wilen M, Ziesche S, Cohn JN. Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy. Am J Cardiol. 51:1983;831-836.
45. Adams KF, Dunlap SH, Sueta CA. Relation between gender, etiology and survival in patient with symptomatic heart failure. J Am Coll Cardiol. 28:1996;1781-1788.
46. Di Carli MF, Davidson M, Little R. Value of metabolic imaging with positron emission tomography in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 73:1994;527-533.
47. Scandinavian Simvastatin Survival Study Group. A randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet. 344:1994;1383-1389.
48. Kjekshus J, Pederson T. Lowering of cholesterol with simvastatin may prevent development of heart failure in patients with coronary heart disease (Abstr). J Am Coll Cardiol. 25:1995;282A.
49. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1992;685-691.
50. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 325:1991;293-302.
51. Acute Infarction Ramipril Efficacy (AIRE) Investigators. Effects of ramipril on morbidity and mortality of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet. 342:1993;821-828.
52. Packer M, Bristow MR, Cohn JN. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 334:1996;1349-1355.
53. Waagstein F, Bristow MR, Swedberg K. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy: Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group. Lancet. 342:1993;1441-1446.
54. CIBIS Investigators and Committees. A randomised trial of Beta-blockade in heart failure: The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation. 90:1994;1765-1773.
55. Packer M, O'Conner CM, Ghali JK. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. N Engl J Med. 335:1996;1107-1114.
56. Pouleur H, Rousseau MF. Nisoldipine in ischaemic left ventricular dysfunction. Eur Heart J. 14 (Suppl A):1993;45-47.
57. Carmelo A, Milano MD, William D. Coronary artery bypass in patients with severely depressed ventricular function. Ann Thorac Surg. 56:1993;487-493.
58. Rahimtoola SH. Coronary bypass surgery for chronic angina - 1981: a perspective. Circulation. 65:1982;225-241.
59. Alderman EL, Bourassa MG, Cohen LS, CASS investigators. Ten year follow up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 82:1990;1629-1646.
60. Bounous EP, Mark DB, Pollock BG. Surgical survival benefits for coronary disease patients with left ventricular dysfunction. Circulation. 78 (Suppl):1988;1-157.
61. RITA-2 trial participants. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet. 350:1997;461-468.
62. Gioia G, Powers J, Heo J. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischaemic cardiomyopathy. Am J Cardiol. 75:1995;759-762.
63. Dreyfus G, Duboc D, Blasco A. Coronary surgery can be an alternative to heart transplantation in selected patients with end-stage ischaemic heart disease (Abstr). Eur J Cadiothorac Surg. 7:1993;482-487.
64. Di Carli MF, Asgarzadie F, Schelbert HR. Quantitative relationship between myocardial viability and improvement in heart failure symptoms after revascularisation in patients with ischaemic cardiomyopathy. Ciculation. 92:1995;3436-3444.
65. Townsend JN, Pagano D, Allen SM. Results of surgical revascularisation in ischaemic heart failure without angina. Eur J Cardiothorac Surg. 9:1995;507-510.